Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
11 | 116794363 | upstream gene variant | C/T | snv | 0.17 |
|
0.800 | 1.000 | 5 | 2012 | 2019 | ||||||||||
|
11 | 116794363 | upstream gene variant | C/T | snv | 0.17 |
|
0.800 | 1.000 | 2 | 2012 | 2018 | ||||||||||
|
11 | 116794363 | upstream gene variant | C/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 11 | 116790385 | missense variant | G/A;T | snv | 2.0E-05 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 11 | 116790802 | frameshift variant | G/- | del | 6.0E-05 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.080 | 11 | 116790802 | frameshift variant | G/- | del | 6.0E-05 | 7.0E-06 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.925 | 0.080 | 11 | 116790561 | missense variant | C/T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.080 | 11 | 116790561 | missense variant | C/T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.080 | 11 | 116790561 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
11 | 116793250 | upstream gene variant | G/A | snv | 5.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
11 | 116793250 | upstream gene variant | G/A | snv | 5.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Nutritional and Metabolic Diseases | 0.100 | 0.900 | 10 | 2011 | 2017 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
0.800 | 1.000 | 8 | 2012 | 2019 | ||||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
0.800 | 1.000 | 7 | 2012 | 2019 | ||||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Cardiovascular Diseases | 0.070 | 1.000 | 7 | 2010 | 2019 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.060 | 1.000 | 6 | 2012 | 2018 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.050 | 1.000 | 5 | 2011 | 2015 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Nutritional and Metabolic Diseases | 0.030 | 1.000 | 3 | 2012 | 2016 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2014 | 2018 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||||
|
0.689 | 0.480 | 11 | 116792991 | upstream gene variant | G/A | snv | 0.90 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 |